Fear of new or recurrent melanoma after treatment for localised melanoma
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: To estimate the amount of fear of new or recurrent melanoma among people treated for localised melanoma in an Australian specialist centre. Methods: We randomly selected 400 potential participants from all those treated for localised melanoma at the Melanoma Institute Australia during 2014 (n = 902). They were asked to complete an adapted version of the Fear of Cancer Recurrence Inventory (FCRI). We calculated summary statistics for demographics, clinical variables and total FCRI and subscale scores. Results: Two hundred fifteen people (54%) completed the FCRI questionnaire. The overall mean severity subscale score was 15.0 (95% CI 14.0‐16.1). A high proportion of participants had scores above a proposed threshold to screen for clinical fear of cancer recurrence (77% and 63% of participants with and without new or recurrent melanoma had severity subscale scores ≥13). Most participants also had scores above a threshold found to have high specificity for clinical fear of cancer recurrence (65% and 48% of participants with and without new or recurrent melanoma had severity subscale scores ≥16). The severity subscale appeared to discriminate well between groups with differing levels of risk of new or recurrent melanoma. Conclusions: There is a substantial amount of fear of new or recurrent melanoma among this population, despite most having a very good prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 2×
“Fear of cancer recurrence is multidimensional in nature, comprising of cognitions, beliefs, and emotions which manifest along a continuum from normal reactions through to clinical manifestations.(16) A valid and reliable way to measure fear of cancer recurrence is using a questionnaire called the Fear of Cancer Recurr…”
MethodSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · cited 4×
“6, respectively.(17) We estimated that 50% of individuals we approachedwould agree to participate, and so approached 400 people.”
BackgroundMethodResultInfluentialLebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586
Screening and comorbidity of clinical levels of fear of cancer recurrence
Simard, S., & Savard, J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0424-4 · Cited by 329 · cited 2×
“A recent study of 60 people with a history of cancer evaluated different thresholds of severity subscale scores against a reference standard of clinical fear of cancer recurrence.(21) The authors applied the DSM‐ IV(24) definition of mental disorders when conducting semistructured interviews with participants in order…”
MethodDieng, M., Butow, P. N., Costa, D. S. J., Morton, R. L., Menzies, S. W., Mireskandari, S., Tesson, S., Mann, G. J., Cust, A. E., & Kasparian, N. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2278 · Cited by 123
Self-citationMutsaers, B., Jones, G., Rutkowski, N., Tomei, C., Séguin Leclair, C., Petricone-Westwood, D., Simard, S., & Lebel, S. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3248-5 · Cited by 109 · cited 2×
“The transactional model of stress and coping has been proposed as a useful theoretical framework for thinking about and exploring individual experiences of health threat, including fear of new or recurrent melanoma.(25) According to this model, key components of the coping process include efforts to regulate the stres…”
BackgroundEmpirical validation of the English version of the Fear of Cancer Recurrence Inventory
Lebel, S., Simard, S., Harris, C., Feldstain, A., Beattie, S., McCallum, M., Lefebvre, M., Savard, J., & Devins, G. M. (2016) · Quality of Life Research · doi:10.1007/s11136-015-1088-2 · Cited by 90
Research works printed but not linked: 23
- 10.1016/j.clindermatol.2008.09.001 · DOI · Paper page
- 10.1111/j.1365-2133.2009.09299.x · DOI
- 10.1007/s10552-005-3637-4 · DOI · Paper page
- 10.1136/bmj.38516.649537.E0 · DOI · Paper page
- 10.1001/jamadermatol.2013.9852 · DOI
- 10.1111/jdv.12887 · DOI
- 10.1634/theoncologist.2010-0340 · DOI
- 10.1200/JCO.2011.38.8561 · DOI · Paper page
- 10.1093/annonc/mdu366 · DOI
- 10.1177/1049732312448542 · DOI · Paper page
- 10.1016/j.ejso.2012.12.017 · DOI
- 10.1002/pon.4002 · DOI
- 10.1002/cncr.21488 · DOI · Paper page
- 10.1007/s00520‐016‐3378‐9 · DOI
- 10.1002/pon.3718 · DOI
- 10.1001/archdermatol.2009.308 · DOI · Paper page
- 10.1002/pon.4018 · DOI
- 10.1007/s00520-015-2943-y · DOI
- 10.1176/appi.books.9780890423349 · DOI · Paper page
- 10.1245/s10434-016-5263-7 · DOI
- 10.1097/CMR.0000000000000204 · doi:10.1097/cmr.0000000000000204
- 10.1111/jocn.12758 · DOI
- 10.1159/000057992 · DOI
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
“Endometrial cancer 123 (61) 24 (12) 34 (17) 22 (11) 15 (38) 9 (23) 8 (21) 8 (19)”
Self-citationSpotlight on the Fear of Cancer Recurrence Inventory (FCRI)
Smith, A. B., Costa, D., Galica, J., Lebel, S., Tauber, N., van Helmondt, S. J., & Zachariae, R. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s231577 · Cited by 98
Current directions in research and treatment of fear of cancer recurrence
Sharpe, L., Thewes, B., & Butow, P. (2017) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000288 · Cited by 37
Metadata
- Authors
- Bell, K. J. L., Mehta, Y., Turner, R. M., Morton, R. L., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., Irwig, L., & Webster, A. C.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2017-02-02
- Volume
- 26
- Issue
- 11
- Pages
- 1784-1791
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2567856510
- Cited by
- 66
- References
- 7
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fear of new or recurrent melanoma after treatment for localised melanoma. https://app.cochat.ai/papers/10.1002/pon.4366
- The paper
- Bell, K. J. L., Mehta, Y., Turner, R. M., Morton, R. L., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., Irwig, L., & Webster, A. C. (2017). Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-Oncology. https://doi.org/10.1002/pon.4366
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.